Tuesday, December 02, 2008
 
 
  Home arrow Abstinence arrow Quotes to Note arrow It's not the funds.ESCR
Main Menu
Home
About Us
Current Headlines
Abortion
Abstinence
Birth Control
End of Life / Euthanasia
Medical Research
Medical Students
Population
Position Statements
Pregnancy/Development
STDs
Stem Cells & Cloning
Contact Us
Web Links
Site Index
Resources
Related Items
Translator
Quotes to Note

A 13-year study of pregnancy-associated deaths, published in the American Journal of Obstetrics and Gynecology, found that the maternal mortality rate associated with abortion is 2.95 times higher than the maternal mortality rate associated with pregnancies carried to term.

The study included the entire population of women 15-49 years of age in Finland, 1987-2000. The researchers linked birth and abortion records to death certificates.

The annual death rate of women who had abortions in the previous year was also 46% higher than that of non-pregnant women.

Women who carried to term (gave birth) had a significantly lower death rate than non-pregnant women.

Non-pregnant women had 57.0 deaths per 100,000, compared to only 28.2 for women who carried to term (gave birth), 51.9 for women who miscarried, and 83.1 deaths for women who had abortions.

[Gissler M, Berg C, Bouvier-Colle MH, Buekens P. Pregnancy-associated mortality after birth, spontaneous abortion or induced abortion in Finland, 1987-2000. Am J Ob Gyn 2004; 190:422-427. Finland National Research and Development Center]

 
It's not the funds.ESCR PDF Print E-mail

It's not the FUNDS that are Lacking for Embryonic Stem Cell Research.
It's the Results.

Successful human trials/treatments using Embryonic Stem Cells: 0
Successful human trials/treatments/cures using Adult Stem Cells: 72
 
FDA approved human trials using embryonic stem cells -- 0
FDA approved clinical trials using adult stem cells -- 1,181
 
Embryonic stem cells have been used in ANIMAL trials for 25 years.
After 25 years, and many thousands of dead mice and rats, ESCs have not been shown safe enough for trials in humans, mainly because of their propensity to form tumors (grow uncontrollably), and because of their rejection problems.


[Life Insight, June-July 2006]

 
< Prev   Next >


Go to top of page  Home | About Us | Current Headlines | Abortion | Abstinence | Birth Control | End of Life / Euthanasia | Medical Research | Medical Students | Population | Position Statements | Pregnancy/Development | STDs | Stem Cells & Cloning | Contact Us | Web Links | Site Index | Resources |
 
PhysiciansForLife.org Copyright (C) 2004-2008 All Rights Reserved